MAGEB1 | Melanoma antigen family B, 1 | | | | | | Tissue enriched |
TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | | | | | | Expressed in all |
DMD | Dystrophin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Mixed |
XK | X-linked Kx blood group (McLeod syndrome) | Blood group antigen proteins Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CYBB | Cytochrome b-245, beta polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
DYNLT3 | Dynein, light chain, Tctex-type 3 | Predicted secreted proteins
| | | | | Expressed in all |
RPGR | Retinitis pigmentosa GTPase regulator | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
TSPAN7 | Tetraspanin 7 | CD markers Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CXorf38 | Chromosome X open reading frame 38 | | | | | | Expressed in all |
USP9X | Ubiquitin specific peptidase 9, X-linked | Enzymes
| | | | | Expressed in all |
DDX3X | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MAOA | Monoamine oxidase A | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
MAOB | Monoamine oxidase B | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
RP2 | Retinitis pigmentosa 2 (X-linked recessive) | Disease related genes
| | | | | Mixed |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
NDUFB11 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
RBM10 | RNA binding motif protein 10 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
UBA1 | Ubiquitin-like modifier activating enzyme 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CDK16 | Cyclin-dependent kinase 16 | Enzymes
| | | | | Expressed in all |
USP11 | Ubiquitin specific peptidase 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
TIMP1 | TIMP metallopeptidase inhibitor 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
UXT | Ubiquitously-expressed, prefoldin-like chaperone | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
SPACA5 | Sperm acrosome associated 5 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
SPACA5B | Sperm acrosome associated 5B | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
FTSJ1 | FtsJ RNA methyltransferase homolog 1 (E. coli) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EBP | Emopamil binding protein (sterol isomerase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
RBM3 | RNA binding motif (RNP1, RRM) protein 3 | Predicted secreted proteins
| | | | | Expressed in all |
WDR13 | WD repeat domain 13 | | | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes
| | | | | Mixed |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
PQBP1 | Polyglutamine binding protein 1 | Disease related genes
| | | | | Expressed in all |
SLC35A2 | Solute carrier family 35 (UDP-galactose transporter), member A2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TFE3 | Transcription factor binding to IGHM enhancer 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
PRAF2 | PRA1 domain family, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
GPKOW | G patch domain and KOW motifs | | | | | | Expressed in all |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PAGE1 | P antigen family, member 1 (prostate associated) | | | | | | Tissue enriched |
AKAP4 | A kinase (PRKA) anchor protein 4 | Cytoskeleton related proteins
| | | | | Tissue enriched |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
GSPT2 | G1 to S phase transition 2 | | | | | | Expressed in all |
XAGE2B | X antigen family, member 2B | | | | | | Tissue enriched |
XAGE2 | X antigen family, member 2 | | | | | | Tissue enriched |
SSX2 | Synovial sarcoma, X breakpoint 2 | Cancer-related genes Disease related genes
| | | | | Tissue enriched |